The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | The CLL epigenome
Elias Campo
• 25 Oct 2018
Elias Campo, MD, PhD, of the University of Barcelona, Barcelona, Spain, discusses the pathogenesis of chronic lymphocytic leukemia (CLL), including the role of the epigenome in this process, which is becoming increasingly apparent. This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
